TNXP

Tonix Pharmaceuticals Holding Corp.

TNXP | NASDAQ Capital Market

0.6116USD0.0416 %

Break down Tonix Pharmaceuticals Holding Corp.'s income statement to see revenues, costs, and profitability metrics.

Annual
Breakdown2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Total Revenue
7.77 M
0
0
0
0
0
0
0
Cost of Revenue
4.74 M
%-95.77
112.09 M
%21.43
92.31 M
%82.76
50.51 M
%75.22
28.83 M
%9.52
26.32 M
%23.63
21.29 M
%-45.36
38.97 M
Gross Profit
3.03 M
%-102.70
-112.09 M
%21.43
-92.31 M
%82.76
-50.51 M
%75.22
-28.83 M
%9.52
-26.32 M
%23.63
-21.29 M
%-45.36
-38.97 M
Operating Expenses
121.41 M
%8.31
112.09 M
%21.43
92.31 M
%82.76
50.51 M
%75.22
28.83 M
%9.52
26.32 M
%23.63
21.29 M
%-45.36
38.97 M
Operating Income
-118.38 M
%5.61
-112.09 M
%21.43
-92.31 M
%82.76
-50.51 M
%75.22
-28.83 M
%9.52
-26.32 M
%23.63
-21.29 M
%-45.36
-38.97 M
Income Before Tax
-116.66 M
%5.84
-110.22 M
%19.43
-92.29 M
%82.88
-50.46 M
%76.33
-28.62 M
%9.69
-26.09 M
%23.51
-21.12 M
%-45.62
-38.84 M
Net Income
-116.66 M
%-0.19
-116.88 M
%26.65
-92.29 M
%76.88
-52.17 M
%67.81
-31.09 M
%5.92
-29.36 M
%38.97
-21.12 M
%-45.62
-38.84 M
Basic EPS
-219.09
%-65.78
-640.26
%-60.50
-1.62 K
%-54.08
-3.53 K
0
0
0
0
EPS Diluted
-219.09
%-65.78
-640.26
%-60.50
-1.62 K
%-54.08
-3.53 K
0
0
0
0
Basic Average Shares
532.48 K
%191.70
182.54 K
%220.61
56.94 K
%285.23
14.78 K
0
0
0
0
Diluted Average Shares
532.48 K
%191.70
182.54 K
%220.61
56.94 K
%285.23
14.78 K
0
0
0
0
EBITDA
-114.09 M
%2.93
-110.84 M
%20.13
-92.26 M
%82.75
-50.48 M
%75.28
-28.8 M
%9.65
-26.27 M
%24.74
-21.06 M
%-45.67
-38.76 M